BioSyent Inc. BIOYF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.14M | 6.54M | 6.45M | 6.18M | 5.92M |
| Total Depreciation and Amortization | 1.45M | 850.60K | 644.20K | 626.00K | 527.30K |
| Total Amortization of Deferred Charges | -27.90K | -31.20K | -34.20K | -9.60K | 28.00K |
| Total Other Non-Cash Items | 142.70K | -19.80K | 35.60K | 170.90K | 150.20K |
| Change in Net Operating Assets | -389.50K | 1.66M | -576.90K | -1.07M | 2.09M |
| Cash from Operations | 8.32M | 9.00M | 6.52M | 5.89M | 8.72M |
| Capital Expenditure | -33.00K | -34.20K | -28.00K | -24.50K | -42.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -16.15M | -16.15M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.79M | 4.26M | 2.95M | 1.86M | -2.14M |
| Cash from Investing | -11.40M | -11.92M | 2.92M | 1.83M | -2.19M |
| Total Debt Issued | 8.00M | 8.00M | -- | -- | -- |
| Total Debt Repaid | -6.33M | -4.24M | -196.70K | -191.50K | -188.10K |
| Issuance of Common Stock | 202.40K | 65.90K | 99.20K | 261.40K | 277.20K |
| Repurchase of Common Stock | -3.65M | -1.93M | -1.01M | -4.78M | -4.79M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -1.67M | -1.61M | -1.57M | -1.55M |
| Other Financing Activities | -52.00K | -48.90K | -49.30K | -51.80K | -54.30K |
| Cash from Financing | -3.03M | -325.00K | -2.42M | -4.96M | -4.93M |
| Foreign Exchange rate Adjustments | 23.20K | 19.80K | -9.30K | 21.90K | -2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.08M | -3.22M | 7.01M | 2.78M | 1.60M |